Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Biomarker and diagnostic research for breast cancer, familial, susceptibility to, 3 has been reported in the published literature.
No clinical trials have been registered for breast cancer, familial, susceptibility to, 3.
21 publications have been identified in PubMed for breast cancer, familial, susceptibility to, 3. Research spans Epidemiology / Natural History (33%), Basic Science / Preclinical (29%), and Review / Meta-Analysis (19%).
Research Type | Count | % of Total |
|---|---|---|
Disease patterns and progression | 7 | 33% |
Data assembled from 2 of 12 sources · Last updated Sep 20, 2026, 11:34 PM UTC
Laboratory research |
6 |
29% |
Research summaries | 4 | 19% |
Testing and diagnosis research | 2 | 10% |
Patient case studies | 2 | 10% |
Gaspar T (2026). [PMID: 42033881](https://pubmed.ncbi.nlm.nih.gov/42033881/). *Clin Breast Cancer*. [Epidemiology / Natural History]
Lubiński K (2026). [PMID: 41828619](https://pubmed.ncbi.nlm.nih.gov/41828619/). *Int J Mol Sci*. [Epidemiology / Natural History]
Asmussen J (2026). [PMID: 41916322](https://pubmed.ncbi.nlm.nih.gov/41916322/). *Am J Hum Genet*. [Basic Science / Preclinical]
Li AQ (2025). [PMID: 40032426](https://pubmed.ncbi.nlm.nih.gov/40032426/). *Zhonghua Bing Li Xue Za Zhi*. [Review / Meta-Analysis]
Hilakivi-Clarke L (2025). [PMID: 40212587](https://pubmed.ncbi.nlm.nih.gov/40212587/). *iScience*. [Review / Meta-Analysis]
Wiese J (2025). [PMID: 40974220](https://pubmed.ncbi.nlm.nih.gov/40974220/). *J Investig Med High Impact Case Rep*. [Case Report / Case Series]
MacInnis RJ (2025). [PMID: 39673461](https://pubmed.ncbi.nlm.nih.gov/39673461/). *JNCI Cancer Spectr*. [Epidemiology / Natural History]
Rashid MU (2025). [PMID: 40749126](https://pubmed.ncbi.nlm.nih.gov/40749126/). *Int J Cancer*. [Basic Science / Preclinical]
Cabello AERDS (2025). [PMID: 40544077](https://pubmed.ncbi.nlm.nih.gov/40544077/). *Clin Breast Cancer*. [Diagnostic / Biomarker]
Kvist A (2025). [PMID: 40922009](https://pubmed.ncbi.nlm.nih.gov/40922009/). *Breast Cancer Res*. [Basic Science / Preclinical]